Does administering dexamethasone in late pregnancy affect the fetus?
In general, whether dexamethasone administered in late pregnancy affects the fetus mainly depends on the dosage. When used in small amounts, it typically has no significant effect; however, when used in large amounts, it may have adverse effects. If any discomfort occurs, prompt medical consultation is recommended. The detailed analysis is as follows:
Dexamethasone, a glucocorticoid medication, is widely used in clinical practice, including specific situations during late pregnancy such as promoting fetal lung maturation. When administered in small doses, the drug is rapidly metabolized by the mother, and only a minimal amount crosses the placental barrier into the fetal circulation. Furthermore, dexamethasone has a relatively short half-life in the fetus, resulting in low potential for accumulation. Under these conditions, its impact on the fetus is considered negligible and generally does not adversely affect fetal growth and development.
However, the situation differs when dexamethasone is used in large doses during late pregnancy. A high dose introduced into the maternal system allows more of the drug to cross the placenta and reach the fetus. Since the fetal metabolic and excretory systems are not yet fully developed, their ability to eliminate the drug is limited, potentially leading to higher drug concentrations accumulating in the fetal body. This may result in various adverse effects, such as impaired fetal growth and neurodevelopment. Additionally, prolonged or excessive use of glucocorticoids may increase the risk of metabolic disorders in newborns, such as hypoglycemia and hypocalcemia.
Pregnant women must strictly adhere to the prescribed dosage and duration when using dexamethasone. During treatment, they should closely monitor their own condition and fetal activity, and seek immediate medical attention if any adverse symptoms occur.